Magano Daniel, Taveira-Gomes Tiago, Massano João, Barros António S
Ph.D. Program in Health Data Science, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Medical Department, BIAL-Portela & Cª., S.A., 4745-457 São Mamede do Coronado, Portugal.
J Clin Med. 2024 Aug 27;13(17):5081. doi: 10.3390/jcm13175081.
: Parkinson's Disease significantly impacts health-related quality of life, with the Parkinson's Disease Questionnaire-39 extensively used for its assessment. However, predicting such outcomes remains a challenge due to the subjective nature and variability in patient experiences. This study develops a machine learning model using accessible clinical data to enable predictions of life-quality outcomes in Parkinson's Disease and utilizes explainable machine learning techniques to identify key influencing factors, offering actionable insights for clinicians. : Data from the Parkinson's Real-world Impact Assessment study (PRISM), involving 861 patients across six European countries, were analyzed. After excluding incomplete data, 627 complete observations were used for the analysis. An ensemble machine learning model was developed with a 90% training and 10% validation split. : The model demonstrated a Mean Absolute Error of 4.82, a Root Mean Squared Error of 8.09, and an R of 0.75 in the training set, indicating a strong model fit. In the validation set, the model achieved a Mean Absolute Error of 11.22, a Root Mean Squared Error of 13.99, and an R of 0.36, showcasing moderate variation. Key predictors such as age at diagnosis, patient's country, dementia, and patient's age were identified, providing insights into the model's decision-making process. : This study presents a robust model capable of predicting the impact of Parkinson's Disease on patients' quality of life using common clinical variables. These results demonstrate the potential of machine learning to enhance clinical decision-making and patient care, suggesting directions for future research to improve model generalizability and applicability.
帕金森病对健康相关生活质量有显著影响,帕金森病问卷-39被广泛用于其评估。然而,由于患者体验的主观性和变异性,预测此类结果仍然是一项挑战。本研究使用可获取的临床数据开发了一种机器学习模型,以预测帕金森病患者的生活质量结果,并利用可解释的机器学习技术识别关键影响因素,为临床医生提供可操作的见解。:分析了来自帕金森病真实世界影响评估研究(PRISM)的数据,该研究涉及六个欧洲国家的861名患者。在排除不完整数据后,627个完整观察值用于分析。开发了一个集成机器学习模型,训练集和验证集的划分比例为90%和10%。:该模型在训练集中的平均绝对误差为4.82,均方根误差为8.09,R值为0.75,表明模型拟合良好。在验证集中,该模型的平均绝对误差为11.22,均方根误差为13.99,R值为0.36,显示出适度的差异。确定了诊断年龄、患者所在国家、痴呆症和患者年龄等关键预测因素,深入了解了模型的决策过程。:本研究提出了一个强大的模型,能够使用常见临床变量预测帕金森病对患者生活质量的影响。这些结果证明了机器学习在增强临床决策和患者护理方面的潜力,为未来研究提高模型的通用性和适用性指明了方向。